Kagawa, Yoshinori http://orcid.org/0000-0001-6876-4507
Wang, Chaochen http://orcid.org/0000-0001-5533-1497
Piao, Yongzhe http://orcid.org/0000-0001-7898-3041
Jin, Long
Tanizawa, Yoshinori http://orcid.org/0000-0002-5014-2483
Cai, Zhihong http://orcid.org/0000-0002-3431-197X
Sunakawa, Yu http://orcid.org/0000-0002-0163-7543
Funding for this research was provided by:
Eli Lilly Japan
Article History
Accepted: 5 April 2024
First Online: 1 May 2024
Declarations
:
: This study was funded by Eli Lilly Japan K.K. Leo J. Philip Tharappel of Eli Lilly Services India Private Limited, Bengaluru, India provided medical writing and editorial support, which was funded by Eli Lilly Japan K.K.
: Yoshinori Kagawa received honoraria from Bayer, Chugai, Eli Lilly Japan K.K., Merck, MSD, Ono, Sanofi, Taiho, Takeda, and Yakult. Chaochen Wang, Yongzhe Piao, Long Jin, Yoshinori Tanizawa, and Zhihong Cai are employees of Eli Lilly Japan K.K. and may hold stock and/or stock options in the company. Yu Sunakawa or his institution received grants or contracts from Chugai, Eli Lilly Japan K.K., Ohtsuka Pharmaceutical, Sanofi, Taiho, and Takeda. He received payments or honoraria from Bayer, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eli Lilly Japan K.K., Guardant Health, Merck Biopharma, MSD, Ono, Sysmex, Taiho, and Takeda. He also participated on an advisory board for Guardant Health, Merck Biopharma, and Ono.
: This study was conducted in accordance with ethical principles originating from the Declaration of Helsinki and that were consistent with Good Pharmacoepidemiology Practices. This study used retrospective de-identified data so an ethical review and informed consent were not required, consistent with the Japanese Ethical Guidelines for Medical and Health Research Involving Human Subjects.
: Not applicable.
: Not applicable.
: The datasets generated and/or analyzed during the current study are available at Eli Lilly Japan K.K on reasonable request.
: Not applicable.
: Conception and design: CW, LJ, YK, YS. Collection and assembly of data: data analysis and/or interpretation: YK, CW, YP, LJ, YT, ZC, YS. Manuscript writing: YK, YS. Final approval of manuscript: YK, CW, YP, LJ, YT, ZC, YS. Accountable for all aspects of the work: YK, CW, YP, LJ, YT, ZC, YS.